Featured Articles
-
Streamlining The Clinical Trial Workflow From Protocol Design To Regulatory Submission
1/27/2026
Learn how to create a direct line from clinical planning and protocol design to clinical trial disclosure to optimize efficiency across the entire trial lifecycle.
-
Changing The Clinical Feasibility Game With AI
1/22/2026
AI is only as good as the data it’s built upon. Our customized AI platforms are constructed on a foundation of trustworthy, carefully curated data to produce detailed, expert-driven responses.
-
Predictions For 2026 In Life Sciences
1/15/2026
Experts predict 2026 trends: more pragmatic trial design, expanded use of data and AI for patient matching, and registration and reporting of results for all human trials.
-
Decision-Ready Data Restores Clinical Teams' Confidence
1/14/2026
The data underlying strategic decisions made by clinical teams often remain fragmented, backward-looking, or insufficiently validated. These teams need decision-ready data that brings clarity where it matters most.
-
No More Swiss Holes: Filling The Gaps In Clinical Trial Disclosure
1/14/2026
This use case shows how sponsors can gain clarity on disclosure requirements when entering a new country.
-
Busting Through Patient Recruitment Barriers
12/8/2025
Building patient trust fuels engagement, data and technology enable targeted recruitment, and real-time patient identification with consistent support drives scalable enrollment success.
-
Clinical Trial Starts Rose At Slower Pace In 2024
12/8/2025
Clinical trial starts grew 5.5% to 10,503 in 2024, a slowdown from 2023’s 9.4% rise in trial starts. Sustained geopolitical and global regulatory pressures on pharma contributed to curbing momentum.
-
Drilling Down On Diversity And Feasibility
12/8/2025
A mid-sized contract research organization (CRO) sought help with writing clinical trial diversity action plans and assessing feasibility for therapeutic areas outside its usual scope.
-
Retention Begins With Recruiting The Right-Fit Patients
11/13/2025
Recruiting the right patients into a clinical trial is only half the battle. To combat attrition, sponsors must also institute measures that ensure patients remain comfortable and confident throughout the trial.
-
4 New Approvals In Q3 Across Gene, Cell, RNA Therapies
11/13/2025
Q3 2025 brought notable progress across the gene, cell, and RNA therapy landscape, marked by four new global approvals. While regulatory progress continued, clinical development activity slowed.